Streptococcus pneumoniae coinfection in hospitalised patients with COVID-19

Eur J Clin Microbiol Infect Dis. 2021 Jun;40(6):1353-1355. doi: 10.1007/s10096-021-04166-w. Epub 2021 Jan 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Adenosine Monophosphate / therapeutic use
  • Adult
  • Aged
  • Aged, 80 and over
  • Alanine / analogs & derivatives
  • Alanine / therapeutic use
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Inflammatory Agents / therapeutic use
  • Antiviral Agents / therapeutic use
  • Azithromycin / therapeutic use
  • COVID-19 / epidemiology*
  • COVID-19 / pathology
  • COVID-19 Drug Treatment*
  • COVID-19 Testing / methods
  • Ceftriaxone / therapeutic use
  • Coinfection / epidemiology*
  • Coinfection / pathology
  • Dexamethasone / therapeutic use
  • Female
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Male
  • Middle Aged
  • Pneumococcal Infections / drug therapy*
  • Pneumococcal Infections / epidemiology*
  • Pneumococcal Infections / pathology
  • SARS-CoV-2 / isolation & purification
  • Streptococcus pneumoniae / isolation & purification

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents
  • Antiviral Agents
  • remdesivir
  • Adenosine Monophosphate
  • Hydroxychloroquine
  • Ceftriaxone
  • Dexamethasone
  • Azithromycin
  • Alanine